Laura Clague
Equibles does not estimate personal net worth.
About Laura Clague
Earlier roles on record: CFO at Travere Therapeutics, Inc. (TVTX) until August 31, 2022. The proxy statement of Travere Therapeutics, Inc. reports total compensation of $1,963,343 for Laura Clague in fiscal 2022, including a base salary of $422,476. Disclosed compensation is on record for 6 fiscal years. Laura Clague has spoken on 10 earnings calls across 1 company, most recently for Travere Therapeutics, Inc. on August 4, 2022. The companies whose calls Laura Clague spoke on are classified in the Healthcare sector.
Laura Clague on recent calls
“For the second quarter of 2022, we reported total revenue of $54.2 million, consisting of approximately $51 million in net product sales and $3.2 million in collaboration revenue from our European collaboration with Vifor Pharma.”
“For the first quarter of 2022, we reported total revenue of $48.5 million, consisting of approximately $46.4 million in net product sales and $2 million in collaboration revenue from our European partnership with Vifor Pharma.”
“For the fourth quarter of 2021, we reported net product sales of $54.6 million from our commercial portfolio compared to $51 million for the same period in 2020.”
“For the third quarter of 2021, we reported net product sales of $54.2 million from our commercial portfolio compared to $51.1 million for the same period in 2020.”
“For the second quarter of 2021, we reported net product sales of $54.6 million from our commercial portfolio, compared to $48.4 million for the same period in 2020.”
Affiliation history
-
Start not stated–2022-08-31
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Travere Therapeutics, Inc. (TVTX) | Former Chief Financial Officer | $422,476 | $1,963,343 |
| 2021 | Travere Therapeutics, Inc. (TVTX) | Former Chief Financial Officer | $452,072 | $1,934,671 |
| 2020 | Travere Therapeutics, Inc. (TVTX) | Former Chief Financial Officer | $436,801 | $1,648,714 |
| 2019 | Travere Therapeutics, Inc. (TVTX) | Senior Vice President and Chief Financial Officer | $419,271 | $1,303,582 |
| 2018 | Travere Therapeutics, Inc. (TVTX) | Senior Vice President and Chief Financial Officer | $399,583 | $1,860,308 |
| 2017 | Travere Therapeutics, Inc. (TVTX) | Senior Vice President and Chief Financial Officer | $382,467 | $1,496,638 |